BioMarin Pharmaceuticals
BMRN
BMRN
570 hedge funds and large institutions have $9.71B invested in BioMarin Pharmaceuticals in 2025 Q3 according to their latest regulatory filings, with 75 funds opening new positions, 224 increasing their positions, 199 reducing their positions, and 73 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
4% less capital invested
Capital invested by funds: $10.1B → $9.71B (-$432M)
1% less funds holding
Funds holding: 578 → 570 (-8)
2.81% less ownership
Funds ownership: 96.22% → 93.41% (-2.8%)
Holders
570
Holding in Top 10
7
Calls
$91M
Puts
$59.3M
Top Buyers
| 1 | +$116M | |
| 2 | +$57.1M | |
| 3 | +$49.1M | |
| 4 |
LSV Asset Management
Chicago,
Illinois
|
+$44M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$36.4M |
Top Sellers
| 1 | -$215M | |
| 2 | -$106M | |
| 3 | -$56.8M | |
| 4 |
Ameriprise
Minneapolis,
Minnesota
|
-$50.5M |
| 5 |
D.E. Shaw & Co
New York
|
-$45.5M |